EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Best anticoagulation strategy with and without appendage occlusion for stroke‐prophylaxis in postablation atrial fibrillation patients with cardiac amyloidosis

Sanghamitra Mohanty iD, Prem Geeta Torlapati, Vincenzo Mirco La Fazia, Merve Kurt, Carola Gianni iD, Bryan MacDonald, Angel Mayedo, John Allison, Mohamed Bassiouny, G Joseph Gallinghouse, John D Burkhardt, Rodney Horton und 3 weitere

Journal of Cardiovascular Electrophysiology · 2024

DOI: 10.1111/jce.16308 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2024. Verfasst von Sanghamitra Mohanty und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrophysiology, Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Stroke, Catheter Ablation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Both atrial fibrillation (AF) and amyloidosis increase stroke risk. We evaluated the best anticoagulation strategy in AF patients with coexistent amyloidosis.

Methods

Consecutive AF patients with concomitant amyloidosis were divided into two groups based on the postablation stroke‐prophylaxis approach; group 1: left atrial appendage occlusion (LAAO) in eligible patients and group 2: oral anticoagulation (OAC). Group 1 patients were further divided into Gr. 1A: LAAO + half‐does NOAC (HD‐NOAC) for 6 months followed by aspirin 81 mg/day and Gr. 1B: LAAO + HD‐NOAC. In group 1 patients, with complete occlusion at the 45‐day transesophageal echocardiogram, patients were switched to aspirin, 81 mg/day at 6 months. In case of leak, or dense “smoke” in the left atrium (LA) or enlarged LA, they were placed on long‐term half‐dose (HD) NOAC. Group 2 patients remained on full‐dose NOAC during the whole study period.

Results

A total of 92 patients were included in the analysis; group 1: 56 and group 2: 36. After the 45‐day TEE, 31 patients from group 1 remained on baby‐aspirin and 25 on HD NOAC. At 1‐year follow‐up, four stroke, one TIA and six device‐thrombus were reported in group 1A, compared to none in patients in group 1B (5/31 vs. 0/25, p = .03). No bleeding events were reported in group 1, whereas group 2 had five bleeding events (one subdural hematoma, one retinal hemorrhage, and four GI bleedings). Additionally, one stroke was reported in group 2 that happened during brief discontinuation of OAC.

Conclusion

In patients with coexistent AF and amyloidosis, half‐dose NOAC following LAAO was observed to be the safest stroke‐prophylaxis strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAtrial AppendageStrokeCatheter AblationAnticoagulantsAmyloidosisHumansMaleFemaleAgedMiddle AgedTreatment OutcomeRisk FactorsTime FactorsHemorrhageAdministration, OralRetrospective StudiesRisk AssessmentAspirinDrug Administration ScheduleCardiomyopathies

Stichwörter der Autor:innen

amyloidosisanticoagulationatrial fibrillationstroke

Substanzen

AnticoagulantsAspirin

Autor:innen und Institutionen

  • Department of Electrophysiology, Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
  • Department of Internal Medicine, Mount Auburn Hospital, Cambridge, Massachusetts, USA.
  • Department of Electrophysiology, Albert Einstein College of Medicine at Montefiore Hospital, New York, New York, USA.
  • Department of Interventional Electrophysiology, Interventional Electrophysiology, Scripps Clinic, San Diego, California, USA.
  • Department of Internal Medicine, Metro Health Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Department of Biomedicine and Prevention, Division of Cardiology, University of Tor Vergata, Rome, Italy.

ORCID-Profile: Sanghamitra Mohanty, Carola Gianni, Luigi Di Biase, Amin Al-Ahmad, Andrea Natale

Zitieren

APA

Mohanty, S., Torlapati, P. G., La Fazia, V. M., Kurt, M., Gianni, C., MacDonald, B., Mayedo, A., Allison, J., Bassiouny, M., Gallinghouse, G. J., Burkhardt, J. D., Horton, R., Di Biase, L., Al-Ahmad, A., & Natale, A. (2024). Best anticoagulation strategy with and without appendage occlusion for stroke‐prophylaxis in postablation atrial fibrillation patients with cardiac amyloidosis. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16308

Vancouver

Mohanty S, Torlapati PG, La Fazia VM, Kurt M, Gianni C, MacDonald B, et al. Best anticoagulation strategy with and without appendage occlusion for stroke‐prophylaxis in postablation atrial fibrillation patients with cardiac amyloidosis. Journal of Cardiovascular Electrophysiology. 2024. doi:10.1111/jce.16308

BibTeX
@article{Mohanty2024,
  author = {Mohanty, Sanghamitra and Torlapati, Prem Geeta and La Fazia, Vincenzo Mirco and Kurt, Merve and Gianni, Carola and MacDonald, Bryan and Mayedo, Angel and Allison, John and Bassiouny, Mohamed and Gallinghouse, G Joseph and Burkhardt, John D and Horton, Rodney and Di Biase, Luigi and Al-Ahmad, Amin and Natale, Andrea},
  title = {Best anticoagulation strategy with and without appendage occlusion for stroke‐prophylaxis in postablation atrial fibrillation patients with cardiac amyloidosis},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2024},
  doi = {10.1111/jce.16308}
}
Kostenlos starten →